The Calcium-Sensing Receptor in the Thick Ascending Limb and the Renal Response to Hypercalcemia.

IF 10.3 1区 医学 Q1 UROLOGY & NEPHROLOGY Journal of The American Society of Nephrology Pub Date : 2025-01-21 DOI:10.1681/ASN.0000000612
Nina Himmerkus, Catarina Quintanova, Harneet Bhullar, Wouter H van Megen, Amanda Lima Deluque, Karsten Skjødt, Milos Bogdanovic, Markus Bleich, Todd Alexander, Henrik Dimke
{"title":"The Calcium-Sensing Receptor in the Thick Ascending Limb and the Renal Response to Hypercalcemia.","authors":"Nina Himmerkus, Catarina Quintanova, Harneet Bhullar, Wouter H van Megen, Amanda Lima Deluque, Karsten Skjødt, Milos Bogdanovic, Markus Bleich, Todd Alexander, Henrik Dimke","doi":"10.1681/ASN.0000000612","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The parathyroid calcium-sensing receptor (CASR) controls the release of parathyroid hormone (PTH) in response to changes in serum calcium levels. Activation of the renal CASR increases urinary calcium excretion and is particularly important when CASR-dependent reductions in PTH fail to lower serum calcium. However, the role of the renal CASR in protecting against hypercalcemia and the direct effects of chronic CASR activation on tubular calcium handling remains to be fully elucidated.</p><p><strong>Methods: </strong>Experimental hypercalcemia was induced using the Vitamin D analog (Dihydrotachysterol, DHT) in mice with Ksp-Cre dependent deletion of the Casr (Ksp-Casr) in kidney with Cre negative littermates (WT) serving as controls. Urinary and fecal electrolyte determinations, dual-energy x-ray absorptiometry, molecular and biochemical evaluation, and in vitro tubule microperfusion were performed in both sexes.</p><p><strong>Results: </strong>Ksp-Cre-driven Casr deletion strongly reduced CASR abundance in the thick ascending limb (TAL). At baseline, no marked differences were detected in electrolyte handling and tubular permeability characteristics across the TAL. 3 days of DHT administration induced hypercalcemia in both WT and Ksp-Casr mice. However, while WT mice developed hypercalciuria, this response was absent in Ksp-Casr mice. Urinary excretion of magnesium and other electrolytes did not differ between hypercalcemic WT and Ksp-Casr mice. Intestinal electrolyte absorption was comparable between the two groups. Microperfusion of isolated cortical TALs revealed no baseline differences in the transepithelial voltage, resistance, or ion permeabilities. Following hypercalcemia, transepithelial resistance increased and calcium permeability markedly decreased in WT mice, but not in Ksp-Casr mice, with only minor alterations in magnesium permeability and no changes in transepithelial voltage.</p><p><strong>Conclusions: </strong>In hypercalcemic mice, absence of the CASR in TAL prevented the increase in urinary calcium excretion. The CASR specifically regulated the paracellular permeability of the TAL, especially for calcium.</p>","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":" ","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1681/ASN.0000000612","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The parathyroid calcium-sensing receptor (CASR) controls the release of parathyroid hormone (PTH) in response to changes in serum calcium levels. Activation of the renal CASR increases urinary calcium excretion and is particularly important when CASR-dependent reductions in PTH fail to lower serum calcium. However, the role of the renal CASR in protecting against hypercalcemia and the direct effects of chronic CASR activation on tubular calcium handling remains to be fully elucidated.

Methods: Experimental hypercalcemia was induced using the Vitamin D analog (Dihydrotachysterol, DHT) in mice with Ksp-Cre dependent deletion of the Casr (Ksp-Casr) in kidney with Cre negative littermates (WT) serving as controls. Urinary and fecal electrolyte determinations, dual-energy x-ray absorptiometry, molecular and biochemical evaluation, and in vitro tubule microperfusion were performed in both sexes.

Results: Ksp-Cre-driven Casr deletion strongly reduced CASR abundance in the thick ascending limb (TAL). At baseline, no marked differences were detected in electrolyte handling and tubular permeability characteristics across the TAL. 3 days of DHT administration induced hypercalcemia in both WT and Ksp-Casr mice. However, while WT mice developed hypercalciuria, this response was absent in Ksp-Casr mice. Urinary excretion of magnesium and other electrolytes did not differ between hypercalcemic WT and Ksp-Casr mice. Intestinal electrolyte absorption was comparable between the two groups. Microperfusion of isolated cortical TALs revealed no baseline differences in the transepithelial voltage, resistance, or ion permeabilities. Following hypercalcemia, transepithelial resistance increased and calcium permeability markedly decreased in WT mice, but not in Ksp-Casr mice, with only minor alterations in magnesium permeability and no changes in transepithelial voltage.

Conclusions: In hypercalcemic mice, absence of the CASR in TAL prevented the increase in urinary calcium excretion. The CASR specifically regulated the paracellular permeability of the TAL, especially for calcium.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
厚升肢钙敏感受体与肾对高钙血症的反应。
背景:甲状旁腺钙敏感受体(CASR)控制甲状旁腺激素(PTH)的释放,以响应血清钙水平的变化。肾CASR的激活增加尿钙排泄,当甲状旁腺激素依赖CASR的减少不能降低血清钙时,这一点尤为重要。然而,肾脏CASR在预防高钙血症中的作用以及慢性CASR激活对小管钙处理的直接影响仍有待充分阐明。方法:用维生素D类似物(二氢快胆固醇,DHT)诱导Ksp-Cre依赖性缺失小鼠肾脏Casr (Ksp-Casr),以Cre阴性窝鼠(WT)为对照。对男女患者进行尿液和粪便电解质测定、双能x线吸收测定、分子和生化评价以及体外小管微灌注。结果:ksp - cred驱动的Casr缺失强烈降低了厚升肢(TAL)中Casr的丰度。在基线时,在整个TAL中没有检测到电解质处理和管状通透性特征的显着差异。DHT给药3天后,WT和Ksp-Casr小鼠均出现高钙血症。然而,当WT小鼠出现高钙尿时,这种反应在Ksp-Casr小鼠中不存在。尿中镁和其他电解质的排泄在高钙WT和Ksp-Casr小鼠之间没有差异。两组之间的肠道电解质吸收具有可比性。对分离的皮质细胞进行微灌注后发现,在经上皮电压、电阻或离子渗透性方面没有基线差异。高钙血症后,WT小鼠的经皮阻力增加,钙通透性明显降低,而Ksp-Casr小鼠则没有,镁通透性只有轻微改变,经皮电压没有变化。结论:在高钙血症小鼠中,TAL中CASR的缺失阻止了尿钙排泄的增加。CASR特异性调节TAL的细胞旁通透性,尤其是钙的通透性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of The American Society of Nephrology
Journal of The American Society of Nephrology 医学-泌尿学与肾脏学
CiteScore
22.40
自引率
2.90%
发文量
492
审稿时长
3-8 weeks
期刊介绍: The Journal of the American Society of Nephrology (JASN) stands as the preeminent kidney journal globally, offering an exceptional synthesis of cutting-edge basic research, clinical epidemiology, meta-analysis, and relevant editorial content. Representing a comprehensive resource, JASN encompasses clinical research, editorials distilling key findings, perspectives, and timely reviews. Editorials are skillfully crafted to elucidate the essential insights of the parent article, while JASN actively encourages the submission of Letters to the Editor discussing recently published articles. The reviews featured in JASN are consistently erudite and comprehensive, providing thorough coverage of respective fields. Since its inception in July 1990, JASN has been a monthly publication. JASN publishes original research reports and editorial content across a spectrum of basic and clinical science relevant to the broad discipline of nephrology. Topics covered include renal cell biology, developmental biology of the kidney, genetics of kidney disease, cell and transport physiology, hemodynamics and vascular regulation, mechanisms of blood pressure regulation, renal immunology, kidney pathology, pathophysiology of kidney diseases, nephrolithiasis, clinical nephrology (including dialysis and transplantation), and hypertension. Furthermore, articles addressing healthcare policy and care delivery issues relevant to nephrology are warmly welcomed.
期刊最新文献
Testing Interventions that Address Kidney Health Disparities. Better Dialysis Care in the United States Requires New Payment Policy: No Patient Left Behind. Bundle Fix?: We Need an Act of Congress. Optimizing Quality Care within a Bundled Framework. Toward Noninvasive Biomarkers of Renal Senescence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1